- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07269054
Effects of Home-based Respiratory Muscle Training With New Load Adjustment Test in People With Multiple Sclerosis
Validation of the New Protocol Based on the Principles of the 1-repetition Maximum Test for Evaluating Maximum Respiratory Pressures in Individuals With Multiple Sclerosis.
Study Overview
Status
Conditions
Detailed Description
It is a single-blind randomized clinical trial study. Each participant will be randomly assigned to one of the following groups: 1) Inspiratory muscle training + Expiratory muscle training with load adjustment based on the principles of the 1-repetition maximum (RM) test , 2) Inspiratory muscle training + Expiratory muscle training with convetional load adjustment.
Each exercise training program will be applied twice (morning inspiratory muscle training session and evening expiratory muscle training session) per day 5 sessions per week during 8 weeks by a threshold device. The sessions will be supervised by a physiotherapist through a virtual platform.
Participants received baseline assessments at the beginning of the intervention, at the end of the 4th week (only the group 2), and post-intervention assessments at the end of the 8th week.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tamara del Corral Núñez-Flores del Corral Núñez-Flores, PhD
- Phone Number: +34 91 394 1517
- Email: tamdelco@ucm.es
Study Contact Backup
- Name: Ibai López de Uralde Villanueva Ibai López de Uralde Villanueva, PhD, PhD
- Phone Number: 1517 +34 91 394 1517
- Email: ibai.lope@ucm.es
Study Locations
-
-
Madrid
-
Móstoles, Madrid, Spain
- Asociación Mostoleña de Esclerosis Múltiple
-
Contact:
- Vanesa Mellado Rubio
- Phone Number: 0034 91 664 38 80
- Email: asociacion@amdem.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Presence of Multiple Sclerosis disease
- Age 18 years or older
- Clinical stability
Exclusion Criteria:
- Any condition that contraindicate respiratory muscle training
- Inability to close the lips to hold the training device's mouthpiece (e.g., facial paralysis)
- Pregnancy
- Inability to adhere to remote monitoring
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Respiratory muscle training + 1-repetition maximum test
Participants will perform an inspiratory and expiratory muscle training program by a threshold device at home, twice a day (morning inspiratory muscle training session and evening expiratory muscle training session) for 8 weeks supervised by a physiotherapist through a virtual platform.
The load adjustment will be based on the principles of the 1-repetition maximum (RM) test.
|
Participants will engage in respiratory muscle training programme at home using a respiratory muscle training threshold device .
This training will be conducted twice daily, five days a week, for eight weeks, with physiotherapist supervision provided by telerehabilitation.
The load adjustment will be based on the principles of the 1-repetition maximum (RM) test.
|
|
Active Comparator: Respiratory muscle training + reference test
Participants will perform an inspiratory and expiratory muscle training program by a threshold device at home, twice a day (morning inspiratory muscle training session and evening expiratory muscle training session) for 8 weeks supervised by a physiotherapist through a virtual platform.
The load adjustment will be based on the conventional test to be performed during the 4th week.
|
Participants will perform an inspiratory and expiratory muscle training program by a threshold device at home, twice a day (morning inspiratory muscle training session and evening expiratory muscle training session) for 8 weeks supervised by a physiotherapist through a virtual platform.
The load adjustment will be based on the conventional test to be performed during the 4th week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory muscle strength
Time Frame: Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
Maximal inspiratory preassure and Maximal expiratory preassure
|
Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
|
Inspiratory muscle endurance
Time Frame: Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
Inspiratory muscle endurance will be assed by an incremental load test that required subjects to breathe against inspiratory threshold loads that were increased each minute by 10% of baseline PI,max until voluntary task failure muscle endurance test.
Inspiratory muscle endurance was defined as the PI,max sustained for a minimum of 1 min.
|
Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health related quality of life
Time Frame: Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
To evaluate the health-related quality of life of the participants a valid, reliable and generic questionnaire will be used.
EuroQol-five-dimensional Questionnaire a numerical value represented Health state as EQ-5D 'index values' or 'index scores' reflecting how good or bad a health state is.
It consisted of five dimensions (Mobility, Self-care, Usual activities, Pain & discomfort, Anxiety & depression), each of which has five severity levels that are described by statements appropriate to that dimension.
|
Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
|
Fatigue
Time Frame: Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
Modified Fatigue Impact Scale (MFIS).
The MFIS is a valid and reliable instrument for assessing fatigue severity.
It consists in 21 items.
Higher scores mean a worse fatigue.
|
Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
|
Fragility
Time Frame: Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
Frailty indexes (FI) and the Comprehensive GeriatricAssessment (CGA) are multidimensional tools.
FI serve to quantitatively measure frailty levels.
They have shown to have an excellent correlation with mortality.
|
Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
|
Degree of disability
Time Frame: Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
The Barthel index (BI) is a 10-item activities of daily living ordinal scale used primarily for disability measurement.
The values assigned to each item are based on the time and amount of physical assistance required for a patient to perform a common daily activity.
|
Pre -intervention and at the end of the respiratory muscle training (8 weeks)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Autoimmune Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Multiple Sclerosis
- Therapeutics
- Mind-Body Therapies
- Complementary Therapies
- Exercise Movement Techniques
- Physical Therapy Modalities
- Breathing Exercises
Other Study ID Numbers
- 24/119-E_BC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Respiratory muscle training + 1-repetition maximum test
-
Pakistan Society for Rehabilitation of Differently...University of KarachiRecruitingResistance TrainingPakistan
-
Federal University of Rio Grande do SulEnrolling by invitationInvestigating the Effects of Power Training in the ElderlyBrazil
-
Hospital Angeles LomasUnknown
-
Swiss Federal Institute of TechnologyCompleted
-
University of FloridaUniversity of Florida Clinical and Translational Science Institute (CTSI)Completed
-
Marmara UniversityCompleted
-
University ToltecaCompleted
-
Institute of Sport - National Research Institute...CompletedAthletic PerformancePoland
-
Ran ShiRecruitingStroke | Hemiplegia | Physical Disability | Rehabilitation; Tobacco UseChina
-
Abant Izzet Baysal UniversityNot yet recruitingChronic Obstructive Pulmonary Disease